Literature DB >> 31996378

Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.

Kazuki Irie1, Tomoaki Nagai1, Kensaku Mizuno2.   

Abstract

The Hippo signaling pathway suppresses cell proliferation and tumorigenesis. In the canonical Hippo pathway, large tumor suppressor kinases 1/2 (LATS1/2) phosphorylate the transcriptional coactivator yes-associated protein (YAP) and thereby suppress its nuclear localization and co-transcriptional activity. Nuclear Dbf2-related kinases 1/2 (NDR1/2), which are closely related to LATS1/2, also phosphorylate and inactivate YAP by suppressing its nuclear localization. Furry (FRY) is a cytoplasmic protein that associates with NDR1/2 and activates them, but its role in the nuclear/cytoplasmic localization of YAP remains unknown. Here, we constructed FRY-knockout cell lines to examine the role of FRY in YAP's cytoplasmic localization. FRY depletion markedly increased YAP nuclear localization and decreased NDR1/2 kinase activity and YAP phosphorylation levels, but did not affect LATS1/2 kinase activity. This indicated that FRY suppresses YAP's nuclear localization by promoting its phosphorylation via NDR1/2 activation. NDR1/2 depletion also promoted YAP nuclear localization, but depletion of both FRY and NDR1/2 increased the number of cells with YAP nuclear localization more strongly than did depletion of NDR1/2 alone, suggesting that FRY suppresses YAP nuclear localization by a mechanism in addition to NDR1/2 activation. Co-precipitation assays revealed that Fry uses its N-terminal 1-2400-amino-acid-long region to bind to YAP. Expression of full-length FRY or its 1-2400 N-terminal fragment restored YAP cytoplasmic localization in FRY-knockout cells. Taken together, these results suggest that FRY plays a crucial role in YAP cytoplasmic retention by promoting YAP phosphorylation via NDR1/2 kinase activation and by binding to YAP, leading to its cytoplasmic sequestration.
© 2020 Irie et al.

Entities:  

Keywords:  Furry (FRY); Hippo pathway; NDR (nuclear Dbf2-related) kinase; cancer; cell signaling; gene knockout; large tumor suppressor kinase (LATS); phosphorylation; protein kinase; yes-associated protein (YAP)

Mesh:

Substances:

Year:  2020        PMID: 31996378      PMCID: PMC7062186          DOI: 10.1074/jbc.RA119.010783

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders.

Authors:  Hossein Najmabadi; Hao Hu; Masoud Garshasbi; Tomasz Zemojtel; Seyedeh Sedigheh Abedini; Wei Chen; Masoumeh Hosseini; Farkhondeh Behjati; Stefan Haas; Payman Jamali; Agnes Zecha; Marzieh Mohseni; Lucia Püttmann; Leyla Nouri Vahid; Corinna Jensen; Lia Abbasi Moheb; Melanie Bienek; Farzaneh Larti; Ines Mueller; Robert Weissmann; Hossein Darvish; Klaus Wrogemann; Valeh Hadavi; Bettina Lipkowitz; Sahar Esmaeeli-Nieh; Dagmar Wieczorek; Roxana Kariminejad; Saghar Ghasemi Firouzabadi; Monika Cohen; Zohreh Fattahi; Imma Rost; Faezeh Mojahedi; Christoph Hertzberg; Atefeh Dehghan; Anna Rajab; Mohammad Javad Soltani Banavandi; Julia Hoffer; Masoumeh Falah; Luciana Musante; Vera Kalscheuer; Reinhard Ullmann; Andreas Walter Kuss; Andreas Tzschach; Kimia Kahrizi; H Hilger Ropers
Journal:  Nature       Date:  2011-09-21       Impact factor: 49.962

2.  NDR2-mediated Rabin8 phosphorylation is crucial for ciliogenesis by switching binding specificity from phosphatidylserine to Sec15.

Authors:  Shuhei Chiba; Yuta Amagai; Yuta Homma; Mitsunori Fukuda; Kensaku Mizuno
Journal:  EMBO J       Date:  2013-02-22       Impact factor: 11.598

3.  Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability.

Authors:  Hauke Cornils; Reto S Kohler; Alexander Hergovich; Brian A Hemmings
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

5.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

6.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 7.  The Hippo pathway and human cancer.

Authors:  Kieran F Harvey; Xiaomeng Zhang; David M Thomas
Journal:  Nat Rev Cancer       Date:  2013-03-07       Impact factor: 60.716

Review 8.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

Review 9.  The NDR/LATS protein kinases in immunology and cancer biology.

Authors:  Ahmad A D Sharif; Alexander Hergovich
Journal:  Semin Cancer Biol       Date:  2017-06-01       Impact factor: 15.707

10.  Jasplakinolide induces primary cilium formation through cell rounding and YAP inactivation.

Authors:  Tomoaki Nagai; Kensaku Mizuno
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

View more
  6 in total

1.  KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.

Authors:  Xiaozheng Sun; Pengxiang Chen; Xue Chen; Wenjing Yang; Xuan Chen; Wei Zhou; Di Huang; Yufeng Cheng
Journal:  Thorac Cancer       Date:  2020-12-21       Impact factor: 3.500

Review 2.  Targeting the Hippo Pathway in Prostate Cancer: What's New?

Authors:  Kelly Coffey
Journal:  Cancers (Basel)       Date:  2021-02-04       Impact factor: 6.575

3.  Furry is required for cell movements during gastrulation and functionally interacts with NDR1.

Authors:  Ailen S Cervino; Bruno Moretti; Carsten Stuckenholz; Hernán E Grecco; Lance A Davidson; M Cecilia Cirio
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

4.  Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.

Authors:  Kentaro Nishi; Wenqiang Fu; Ryoiti Kiyama
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

5.  Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.

Authors:  Zihang Mai; Jianye Yuan; Hong Yang; Shuogui Fang; Xiuying Xie; Xinye Wang; Jiaxin Xie; Jing Wen; Jianhua Fu
Journal:  JCI Insight       Date:  2022-08-22

Review 6.  The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective.

Authors:  Yi Xiao; Jixin Dong
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.